GLP-1 side effects and monitoring: what to expect and when to call

Side effects are the most common reason people stop these medicines, and in my experience many of those stops are avoidable. The dose went up too fast, nobody explained what to eat when appetite disappears, or a manageable symptom was mistaken for a dangerous one. The reverse also happens: a warning sign is dismissed as “just the medication.” Knowing which is which is most of the job.

The common side effects

Both drug labels list gastrointestinal effects at the top: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, bloating, burping and reflux. Headache, fatigue and dizziness are also common, and hair shedding has been reported, particularly with faster weight loss.^1,2 In the large trials, digestive side effects were the most frequent adverse events; most were mild to moderate and occurred mainly during dose escalation.^3,4 Those trials studied the FDA-approved products, and their results cannot be assumed to apply to compounded versions; the FDA notes that many adverse events reported with compounded semaglutide and tirzepatide appear consistent with those of the approved products.⁵

They happen for a predictable reason. These medicines slow the emptying of the stomach and act on appetite centers in the brain. That is part of how they work, and it is why eating the way you used to — a large, rich meal eaten quickly — often produces the worst symptoms.

Practical measures help more than most people expect:

• Eat smaller meals, slowly, and stop at the first sense of fullness.
• Go easy on fatty, fried and very sweet foods, especially in the days after a dose increase.
• Drink fluids steadily through the day; dehydration makes nausea and fatigue worse and strains the kidneys.
• For constipation, increase fluids and fiber gradually, and ask before starting a laxative.
• Put protein first on the plate so that a smaller appetite still covers what your muscles need.

Why the dose goes up slowly

Both medicines start at a low dose that is not intended to be the maintenance dose. The labels step it up at roughly four-week intervals to give the digestive system time to adapt.^1,2 Compounded medications have no FDA-approved dosing schedule, and the FDA has received adverse-event reports that may be related to compounded doses, or dose increases, beyond those in the approved labeling.⁵ The labeled schedule is a maximum pace, not an obligation. If a dose is not tolerated, the next increase can be delayed, and some people do well at a dose below the highest one available.

This is where physician judgment matters most. The decision at each step — increase, hold or reduce — depends on your symptoms, your progress, your hydration and your other medicines. Pushing through significant vomiting to stay on schedule is not a sign of commitment. It is a reason to call.

The serious warnings

The prescribing information for both medicines describes these risks. They are uncommon, but everyone taking the medicine should know them:^1,2

• Thyroid C-cell tumors (boxed warning). Both caused thyroid C-cell tumors in rodents. Whether they do so in humans is unknown. They must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Report a lump or swelling in the neck, hoarseness, trouble swallowing or shortness of breath.
• Acute pancreatitis. Severe, persistent abdominal pain, sometimes spreading to the back, with or without vomiting. Stop the medicine and seek care.
• Gallbladder disease. Gallstones and gallbladder inflammation occurred more often than with placebo. Pain in the upper right abdomen, fever, yellowing of the skin or eyes, or clay-colored stools need evaluation.
• Acute kidney injury. Most reported cases followed dehydration from vomiting or diarrhea, especially during dose increases. The risk is higher if you already have kidney disease.
• Low blood sugar. The risk rises when these medicines are combined with insulin or a sulfonylurea; those doses often need to be reduced.
• Severe allergic reactions. Swelling of the face, lips, tongue or throat, trouble breathing, or a severe rash require emergency care.
• Diabetic retinopathy complications in people with type 2 diabetes, and an increase in resting heart rate with some products.
• Aspiration during anesthesia or deep sedation. Because the stomach empties slowly, tell every surgeon, dentist or endoscopist that you take one of these medicines.

With tirzepatide, oral contraceptives may be less reliable after starting and after each dose increase; the label advises a non-oral or added barrier method for four weeks at those points.²

When to call, and when to seek care now

Call the practice if nausea or diarrhea is stopping you from eating adequately for more than a day or two, if constipation is not responding to simple measures, if you feel dizzy or unusually tired, or if you have a question about a missed or delayed dose.

Seek urgent care or call 911 for severe or persistent abdominal pain; vomiting that means you cannot keep fluids down; very little urine; signs of a severe allergic reaction; fainting; or symptoms of low blood sugar that do not resolve with treatment. Emergency symptoms should never wait for a callback.

What monitoring looks like

PrimeCell’s GLP-1 program uses compounded GLP-1 medications, prescribed only after a physician evaluation. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. They are not the same as, and should not be assumed equivalent to, Wegovy or Zepbound.

In the PrimeCell GLP-1 program, monitoring is built into every visit rather than saved for problems. Before a prescription, labs are reviewed or ordered based on your history — commonly blood sugar and A1c, kidney function, liver tests, lipids and thyroid testing — to set a baseline and look for reasons not to prescribe. Who is a candidate explains that step in detail.

During titration, each follow-up covers side effects, how much you are eating and drinking, weight trend, and whether a dose increase makes sense. As weight falls, blood pressure and diabetes medicines sometimes need to come down, and repeat labs are ordered when your history or symptoms call for them. Later, the focus shifts toward strength, protein and maintenance. The same physician makes each decision, which means the context travels with you from visit to visit.

What the FDA says about unapproved GLP-1 drugs

Demand for these medicines has created a large market in products that are not FDA-approved. This applies directly to PrimeCell patients, because PrimeCell’s program uses compounded GLP-1 medications. The FDA’s page FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss sets out the agency’s position:⁵

• Compounded drugs are not FDA-approved; the FDA does not review them for safety, effectiveness or quality before they are marketed.
• The FDA has received adverse-event reports linked to dosing errors with compounded semaglutide, including patients measuring the wrong amount and doses beyond those in the approved labeling.
• Salt forms of semaglutide (semaglutide sodium and semaglutide acetate) are different active ingredients from the approved products, and the FDA states it is not aware of any lawful basis for their use in compounding.
• For multiple-dose vials of compounded GLP-1s, the FDA recommends discarding the vial 28 days after first use, even if medication remains, and not using an injectable GLP-1 that arrives warm.
• Counterfeit products, and products sold online or labeled “for research purposes” or “not for human consumption,” may contain the wrong ingredient, too much, too little or none.

The FDA advises obtaining these medicines only with a prescription from a licensed healthcare provider, filling them at a state-licensed pharmacy, and reporting problems to MedWatch. Whatever program you use, you are entitled to know what product you are receiving, whether it is FDA-approved or compounded, and which licensed pharmacy compounds or dispenses it — at PrimeCell included. Compounded drugs are also not generic versions of the brand-name products; generics are FDA-approved, and compounded drugs are not.⁶ How to compare weight-loss programs lists the questions worth asking.